Cargando…

Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate

Irinotecan (IRI) loaded actively into PEGylated liposomes via a sucrosulfate gradient has been approved recently to treat advanced pancreatic cancer. In this study, a similar liposomal composition was developed that includes a low mole fraction (1 mol.%) of porphyrin-phospholipid (PoP), a photosensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Sanjana, Sun, Boyang, Jahagirdar, Dushyant, Luo, Dandan, Ortega, Joaquin, Straubinger, Robert M., Lovell, Jonathan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918863/ https://www.ncbi.nlm.nih.gov/pubmed/35290919 http://dx.doi.org/10.1016/j.tranon.2022.101390

Ejemplares similares

Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy
por: Carter, Kevin A, et al.
Publicado: (2016)

Two Laser Treatments Can Improve Tumor Ablation Efficiency of Chemophototherapy
por: Ghosh, Sanjana, et al.
Publicado: (2021)

Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer
por: Adiwijaya, BS, et al.
Publicado: (2017)

Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice
por: Mabrouk, Moustafa T., et al.
Publicado: (2021)

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
por: Barbier, Sandrine, et al.
Publicado: (2023)

Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020)

Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
por: Milano, Gérard, et al.
Publicado: (2022)

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor
por: Wang, Juan, et al.
Publicado: (2021)

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2023)

Ablation of Hypoxic Tumors with Dose-Equivalent Photothermal, but Not Photodynamic, Therapy Using a Nanostructured Porphyrin Assembly
por: Jin, Cheng S., et al.
Publicado: (2013)

Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes
por: Himbert, Sebastian, et al.
Publicado: (2022)

Liposomal Irinotecan for Treatment of Colorectal Cancer in a Preclinical Model
por: Huang, Jiao-Ren, et al.
Publicado: (2019)

Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020)

Alternative conformations and motions adopted by 30S ribosomal subunits visualized by cryo-electron microscopy
por: Jahagirdar, Dushyant, et al.
Publicado: (2020)

Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
por: Woo, Wonhee, et al.
Publicado: (2019)

Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8(+) T‐Cell Responses
por: He, Xuedan, et al.
Publicado: (2021)

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
por: Bang, Kyunghye, et al.
Publicado: (2021)

Fluorescence Lifetime Nanoscopy of Liposomal Irinotecan Onivyde: From Manufacturing to Intracellular Processing
por: Bernardi, Mario, et al.
Publicado: (2023)

Advances in Liposome-Encapsulated Phthalocyanines for Photodynamic Therapy
por: Rak, Jakub, et al.
Publicado: (2023)

Porphyrin–phospholipid liposomes permeabilized by near-infrared light
por: Carter, Kevin A., et al.
Publicado: (2014)

Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study
por: Gupta, Amol, et al.
Publicado: (2023)

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
por: Wu, Huali, et al.
Publicado: (2015)

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan
por: Yu, Kenneth H., et al.
Publicado: (2021)

The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
por: Su, Y.-Y., et al.
Publicado: (2022)

A Malaria Vaccine Adjuvant Based on Recombinant Antigen Binding to Liposomes
por: Huang, Wei-Chiao, et al.
Publicado: (2018)

Liposome Photosensitizer Formulations for Effective Cancer Photodynamic Therapy
por: Fahmy, Sherif Ashraf, et al.
Publicado: (2021)

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum]
Publicado: (2019)

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
por: Li, Zhaohuan, et al.
Publicado: (2021)

Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors
por: Shen, Jie, et al.
Publicado: (2023)

Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil
por: Hare, Jennifer I., et al.
Publicado: (2013)

HAase-sensitive dual-targeting irinotecan liposomes enhance the therapeutic efficacy of lung cancer in animals
por: Zhang, Liang, et al.
Publicado: (2018)

Effective Irinotecan (CPT‐11)‐containing Liposomes: Intraliposomal Conversion to the Active Metabolite SN‐38
por: Sadzuka, Yasuyuki, et al.
Publicado: (1999)

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
por: Bang, Yung‐Jue, et al.
Publicado: (2019)

Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy
por: Awasthi, Niranjan, et al.
Publicado: (2022)

Longitudinal PET Imaging to Monitor Treatment Efficacy by Liposomal Irinotecan in Orthotopic Patient-Derived Pancreatic Tumor Models of High and Low Hypoxia
por: Ventura, Manuela, et al.
Publicado: (2019)

Mechanisms of light‐induced liposome permeabilization
por: Miranda, Dyego, et al.
Publicado: (2016)

Structural consequences of the interaction of RbgA with a 50S ribosomal subunit assembly intermediate
por: Seffouh, Amal, et al.
Publicado: (2019)

In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes.
por: van Leengoed, H. L., et al.
Publicado: (1994)

Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
por: Ait-Oudhia, Sihem, et al.
Publicado: (2014)

Safety and Feasibility of Photodynamic Therapy for Ablation of Peripheral Lung Tumors
por: Bansal, Sandeep, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b38o3asf1mtslnjasnr1635aop